Centese, Inc. Secures Series B Funding and Strengthens Board With New Director
Summary
Company secures funding to fuel expansion of its Thoraguard\xae System; adds veteran medtech leader Timothy Still to Board of DirectorsOMAHA, NE / ACCESSWIRE / November 21, 2023 / Centese, Inc., a leader in digital surgery technology, announces the successful closing of its $15M Series B funding round. "The Thoraguard System, recognized for its innovative solution to improve post-operative care in cardiac and thoracic surgery, has been validated in peer-reviewed clinical studies demonstrating superiority over legacy products. These studies, including those conducted at world-class institutions like Stanford University Medical Center and NYU Langone Health, have highlighted Thoraguards ability to shorten hospital stays, automate care, and provide superior monitoring of critical patient parameters.In a strategic move to strengthen its leadership for this next phase, Centese, Inc. is also excited to announce the appointment of Timothy Still to its Board of Directors. "Tims extensive experience and proven track record leading medtech organizations will be a tremendous asset as we transition Centese into our next phase of growth," said Mr. Luxon. The potential for the Thoraguard System to redefine post-operative care is enormous, and I look forward to contributing to the companys growth and success."